Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
The balance of benefits and risks outside the licensed indication has not been shown to be favourable
the NIHR Be Part of Research portal lists relevant studies
Phase 2 showed 24.2% weight loss at 48 weeks
It also keeps the ratio between them independent, and allows each to be reconstituted, stored and used on its own
The FDA's 2025 guidance on compounded GLP-1 receptor agonists specifically calls out concentration variability as the leading cause of patient-reported dosing errors
Know exactly how to maximize shelf life through optimal storage practices while maintaining safety and effectiveness
US$ 22.66
US$ 24.11
US$ 22.01
US$ 29.93
US$ 20.85
US$ 25.37
